Metasol

Methylprednisolone Hydrogen Succinate, the active ingredient in Metasol, is a corticosteroid (glucocorticoid) presented as an injectable solution for intravenous use. It provides anti‑inflammatory and immunosuppressive therapy for severe allergic reactions, acute asthma or COPD exacerbations, rheumatic and musculoskeletal disorders, dermatologic inflammatory conditions, and adrenal insufficiency. GNH USA supplies Metasol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Metasol is a glucocorticoid that reduces inflammation and modulates immune responses across several disease families.

- Severe allergic reactions: rapid reduction of airway swelling and systemic inflammation. - Acute asthma or COPD exacerbations: improves airflow and decreases bronchial edema. - Rheumatic and musculoskeletal disorders: alleviates joint pain and swelling. - Dermatologic inflammatory conditions: suppresses skin inflammation and erythema. - Adrenal insufficiency (replacement therapy): restores glucocorticoid levels in deficient patients.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Hyperglycemia: elevated blood sugar levels, especially in diabetic patients. - Fluid retention: peripheral edema and weight gain. - Insomnia or mood changes: including anxiety or euphoria. - Increased appetite and mild hypertension.

Serious or Rare Side Effects: - Severe infection risk: due to immunosuppression. - Adrenal suppression or crisis on abrupt discontinuation. - Gastrointestinal bleeding or ulceration. - Anaphylactic reactions. - Psychosis or severe mood disturbances. - Marked hyperglycemia leading to ketoacidosis.

Careful assessment and monitoring are required before and during therapy.

- Monitor blood glucose: patients with diabetes may need dose adjustments. - Assess infection risk: avoid use in active uncontrolled infections. - Tapering required: abrupt cessation can precipitate adrenal crisis. - Use caution in pregnancy: limited data, weigh benefits against potential risks. - Store at ambient temperature: keep in original container, protect from light and moisture.

Drug interactions can modify efficacy or increase toxicity.

Major Interactions (Avoid): - Live vaccines: immunosuppression may reduce efficacy and increase infection risk. - Strong CYP3A4 inducers (e.g., rifampin): may lower glucocorticoid plasma levels. - Concomitant NSAIDs: heightened risk of gastrointestinal bleeding.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): glucocorticoids may enhance anticoagulant effect. - Antidiabetic agents: may require dose adjustments due to hyperglycemia. - ACE inhibitors or ARBs: possible increase in fluid retention and hypertension.